@article{a2f56abd3b914f14b6647760b13a0580,
title = "Reply to Babouee et al",
author = "Jonas Marschall and Bhavan, {Kavita P.} and Olsen, {Margaret A.} and Fraser, {Victoria J.} and Wright, {Neill M.} and Warren, {David K.}",
note = "Funding Information: been a consultant for Steris and Verimetrix and is a member of the speakers{\textquoteright} bureau for Pfizer, Merck, and Cubist Pharmaceuticals. N. M. W. is a consultant for Nuvasive, Orthovita, und Ul-richmedical and has royalties with Nuvasive. D. K. W. is a consultant for 3M Healthcare, CR Bard, and Cardinal Health and receives research funding from Sage Products, Cubist Pharma- ceuticals, and bioM{\'e}rieux. All other authors report no potential conflicts.",
year = "2011",
month = oct,
day = "1",
doi = "10.1093/cid/cir516",
language = "English (US)",
volume = "53",
pages = "748--749",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "7",
}